Objective Capital

Objective Capital Partners, a boutique investment banking firm focused on mergers & acquisitions, and business valuations

[Objective Capital @ObjectiveCap]

Thanks @GBReports for giving our Managing Director the opportunity to highlight the work we are accomplishing in the Healthcare and Life Sciences sector as we move into the challenges and opportunities of 2019. #LifeSciences #healthcare #biotech https://t.co/9TvOGfMiIq

[Objective Capital @ObjectiveCap]

Join @BDPharmaExec, who is moderating a fireside chat breakfast meeting from 7-9AM on January 15 at the Lomas Santa Fe Country Club in Solana Beach on the topic of "Selling a Family Owned Business - Getting Your Thoroughbred to the Finish Line." https://t.co/GfWyG4Q7H7

[Objective Capital @ObjectiveCap]

1 month ago, @MabVaxThera retained @ObjectiveCap as financial advisors to assist in pursuing strategic alternatives including company acquisition and exploring the sale of certain assets. MabVax and Oncotelic now enter into Reverse Merger Discussions. https://t.co/6xjAQJ1GJO

[pharmaboardroom @pharmaboardroom]

10 Articles from Our Contributors You Should Read from #2018: Life Sciences thought-leaders share their insider knowledge. https://t.co/B5p75FSuqk
@rjsaynor @10habits @ObjectiveCap @BDPharmaExec @ThomasCueni @JanssenAP @methylogix @drmarkaware @chesterdavisjr @CarlaMSmith

[Objective Capital @ObjectiveCap]

Our team volunteered at @RealityChangers to help judge the student Speech Tournaments. We're humbled by the drive and tenacity that the students in the Reality Changers program demonstrate, and we look forward to spending time with the organization again.

[Objective Capital @ObjectiveCap]

We're honored that @MaxVabThera has chosen us to advise them on the strategy and sale of their clinical and pre-clinical assets. Interest inquiries should be directed to our managing directors at 858-663-8662.
https://t.co/p83SafogYU

[pharmaboardroom @pharmaboardroom]

"In order to have a successful life sciences R&D program, biotech and pharma companies must develop game-changing therapeutics, companion diagnostics and personalized medicines." David Crean (@BDPharmaExec) MD @ObjectiveCap
https://t.co/LBJRJcG2R0 …

[pharmaboardroom @pharmaboardroom]

David Crean (@BDPharmaExec) Managing Director for @ObjectiveCap examines the venture investment activity in life sciences for 2018.
https://t.co/LBJRJcG2R0
#VentureCapital #lifesciences #biotech #biopharma

[Objective Capital @ObjectiveCap]

Our extensive Life Sciences experience plus our valuations history is what truly separates OCP from other firms offering valuations in this sector. Request a consultation today. #LifeSciences #consultation #experience #strategicpartnership
https://t.co/2fApmNa9EG

[Objective Capital @ObjectiveCap]

With over 60 years experience and 500 real-world advisory transactions, OCP's team will help you capitalize on your opportunities. Request a consultation today. #LifeSciences #consultation #experience #opportunities #business #strategicpartnership
https://t.co/81KQcjAwOj

[Objective Capital @ObjectiveCap]

At OCP we immerse ourselves completely into each client's unique story and business niche to help achieve maximum value and outcomes. Request a consultation today. #LifeSciences #consultation #business #strategicpartnership
https://t.co/crcfzzCZWy

[pharmaboardroom @pharmaboardroom]

Elevated Valuations Across the Board for #lifesciences in 2018
David H Crean (@BDPharmaExec), Managing Director for @ObjectiveCap, a leading investment banking advisory firm examines the #healthcare market for 2018.
https://t.co/9R5Cpj93GB …

[Objective Capital @ObjectiveCap]

At OCP we've skillfully taken our clients from inception through IPO with an evaluation process that provides you with 5 key bullet points to create success. Request a consultation today. #IPO #SuccessFactors #consultation #strategicpartnership
https://t.co/X2rXP57c6f

[Dr. Joanne Kamens @JKamens]

Thanks to the great coaches! Moderator:
Pamela Reeve
Judges:
Lesley Solomon @DanaFarber
David H. Crean, @ObjectiveCap and
Sarah MacDonald @LS_Cares

[pharmaboardroom @pharmaboardroom]

Elevated Valuations Across the Board for #lifesciences in 2018

David H Crean (@BDPharmaExec), Managing Director for @ObjectiveCap, a leading investment banking advisory firm examines the #healthcare market for 2018.
https://t.co/9R5Cpj93GB

[Objective Capital @ObjectiveCap]

OCP's David H. Crean Ph.D. has been selected to sit on the expert judges panel in the @MassBio Petri Dish Nonprofit Pitch challenge to help grow awareness of the #nonprofit community within the life sciences and healthcare ecosystem in Boston, MA. https://t.co/KE1942AOnS

[Objective Capital @ObjectiveCap]

We are pleased to announce that we were the exclusive advisor to @EveryoneCounts on its sale to Votem. Together they will be able to grow their business exponentially. #voting #acquisition #mergers #blockchaintechnology
https://t.co/xIZNVYKlau

[Objective Capital @ObjectiveCap]

We're honored that Trever F. Acers, Managing Director of OCP, has been named in The San Diego 500, the book of Influential Business Leaders, 2018 Trever currently leads all aspects of OCP's investment banking services. #InvestmentBanking #SDBusiness

https://t.co/tPANkwwXUx

[Objective Capital @ObjectiveCap]

We're extremely honored to be named as a finalist for the Valuation Firm of the Year in the 17th Annual M&A Advisor Awards. Thank you for acknowledging the work that we do. #healthcare #Biotechnology #lifescience #businessvaluation

https://t.co/9530dL6Ted

[Objective Capital @ObjectiveCap]

Register now for the July 12 event in La Jolla to learn about the application of Artificial Intelligence and its intersection with Life Science and Healthcare space from keynote speaker and OCP Managing Director, @BDPharmaExec https://t.co/chbFqeLfwr